2008 Summer Meeting
Implementing National Patient Safety Goals on Anticoagulation
Track: Anticoagulation Series
Program Code:104-L05
Date: 9 June 2008
Time: Monday, June 9, 2008
Location:Ballroom 6C - Level 6MEETING PLANNING ASSOCIATE:
Dr. William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
| William E. Dager, PharmD,FCSHP
Pharmacist Specialist, UC Davis Medical Center
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
School of University of California, Davis
William E. Dager, Pharm.D., FSCHP received his doctorate in pharmacy from the University of California, San Francisco (UCSF) and served his residency at the University of California, Davis Medical Center (UCDMC) in Sacramento. He also completed a Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh, School of Pharmacy.
Dr Dager currently holds two academic positions, one as Clinical Professor of Pharmacy at UCSF School of Pharmacy and the other as a Clinical Professor of Medicine at the UCD School of Medicine. As a clinical specialist at UCDMC he is responsible for difficult cases in anticoagulation, pharmacokinetics or other critical care related situations. He also is clinically active with the cardiology service.
Dr Dager is a fellow of the California Society of Hospital Pharmacists, and member of the Sacramento Valley Society of Hospital Pharmacists, the Anticoagulation Forum, International Society of Thrombosis and Haemostasis, American Society of Health System Pharmacists and the American College of Clinical Pharmacy. He also currently serves as an Instructor and Regional Affiliate Faculty in ACLS for the American Heart Association as well as a reviewer and/or editorial board member for multiple medical journals including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP foundation anticoagulation preceptorship.
Dr Dager has authored numerous articles, book chapters and reviews and presented his work internationally. He is the recipient of multiple teaching awards, is an active lecturer; and is involved in several research projects in the areas of anticoagulation, critical care medicine, cardiovascular disease and pharmacokinetics/pharmacodynamics.
|
MODERATOR:
Dr. William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
| William E. Dager, PharmD,FCSHP
Pharmacist Specialist, UC Davis Medical Center
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
School of University of California, Davis
William E. Dager, Pharm.D., FSCHP received his doctorate in pharmacy from the University of California, San Francisco (UCSF) and served his residency at the University of California, Davis Medical Center (UCDMC) in Sacramento. He also completed a Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh, School of Pharmacy.
Dr Dager currently holds two academic positions, one as Clinical Professor of Pharmacy at UCSF School of Pharmacy and the other as a Clinical Professor of Medicine at the UCD School of Medicine. As a clinical specialist at UCDMC he is responsible for difficult cases in anticoagulation, pharmacokinetics or other critical care related situations. He also is clinically active with the cardiology service.
Dr Dager is a fellow of the California Society of Hospital Pharmacists, and member of the Sacramento Valley Society of Hospital Pharmacists, the Anticoagulation Forum, International Society of Thrombosis and Haemostasis, American Society of Health System Pharmacists and the American College of Clinical Pharmacy. He also currently serves as an Instructor and Regional Affiliate Faculty in ACLS for the American Heart Association as well as a reviewer and/or editorial board member for multiple medical journals including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP foundation anticoagulation preceptorship.
Dr Dager has authored numerous articles, book chapters and reviews and presented his work internationally. He is the recipient of multiple teaching awards, is an active lecturer; and is involved in several research projects in the areas of anticoagulation, critical care medicine, cardiovascular disease and pharmacokinetics/pharmacodynamics.
|
PRESENTER(S):
Dr. Edith Nutescu, PharmD, FCCP, Clinical Associate Professor and Director, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy
| Edith A. Nutescu, Pharm.D., is Clinical Associate Professor of Pharmacy Practice at the University of Illinois at Chicago College of Pharmacy and Director of the Antithrombosis Center at the University of Illinois at Chicago Medical Center. Dr. Nutescu is also an Affiliate Faculty at the University of Illinois at Chicago, Center for Pharmacoeconomic Research. She earned her Pharm.D. degree with high honors at the University of Illinois at Chicago College of Pharmacy. After graduation, Dr Nutescu went on to complete an American Society of Health-System Pharmacists (ASHP)–accredited Pharmacy Practice Residency at Lutheran General Hospital–Advocate Health Care and a Primary Care Specialty Residency at the University of Illinois at Chicago Medical Center. As a clinician and educator, Dr. Nutescu has contributed extensively to the care of patients and the education of students and health care providers on topics related to cardiovascular therapeutics. The Antithombosis Center at the University of Illinois at Chicago Medical Center, which Dr. Nutescu directs, has served as a training site and model for pharmacists and other health care providers throughout the US and various other countries such as Thailand, Hong-Kong, Japan, and Singapore.
Dr. Nutescu maintains an active clinical practice and research program. Her research and practice interests are in the areas of thrombosis, antithrombotic therapy, cardiovascular diseases, and stroke. Dr Nutescu has authored or co-authored over 100 scientific articles, book chapters, and abstracts published in the science and medical literature and has served as a reviewer for the literature in her field. She has lectured extensively both nationally and internationally on topics related to hyperlipidemia, thrombosis, stroke, and cardiovascular diseases. Dr. Nutescu serves on the Board of Directors of the Anticoagulation Forum, and was nominated to represent ACCP on the National Consumers League Senior Outpatient Medication Safety Coalition - Oral Anticoagulant National Advisory Board. Dr. Nutescu is the only pharmacist member nominated to serve on the Steering Committee for the National Quality Forum and the Joint Commission on the Accreditation of Healthcare Organizations - National Consensus Standards for the Prevention and Care of Venous Thrombosis.
|
Dr. William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
| William E. Dager, PharmD,FCSHP
Pharmacist Specialist, UC Davis Medical Center
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
School of University of California, Davis
William E. Dager, Pharm.D., FSCHP received his doctorate in pharmacy from the University of California, San Francisco (UCSF) and served his residency at the University of California, Davis Medical Center (UCDMC) in Sacramento. He also completed a Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh, School of Pharmacy.
Dr Dager currently holds two academic positions, one as Clinical Professor of Pharmacy at UCSF School of Pharmacy and the other as a Clinical Professor of Medicine at the UCD School of Medicine. As a clinical specialist at UCDMC he is responsible for difficult cases in anticoagulation, pharmacokinetics or other critical care related situations. He also is clinically active with the cardiology service.
Dr Dager is a fellow of the California Society of Hospital Pharmacists, and member of the Sacramento Valley Society of Hospital Pharmacists, the Anticoagulation Forum, International Society of Thrombosis and Haemostasis, American Society of Health System Pharmacists and the American College of Clinical Pharmacy. He also currently serves as an Instructor and Regional Affiliate Faculty in ACLS for the American Heart Association as well as a reviewer and/or editorial board member for multiple medical journals including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP foundation anticoagulation preceptorship.
Dr Dager has authored numerous articles, book chapters and reviews and presented his work internationally. He is the recipient of multiple teaching awards, is an active lecturer; and is involved in several research projects in the areas of anticoagulation, critical care medicine, cardiovascular disease and pharmacokinetics/pharmacodynamics.
|
Dr. Ann Wittkowsky, PharmD, CACP, Director, Anticoagulation Services, University of Washington Medical Center
| Ann K. Wittkowsky PharmD CACP FASHP FCCP is Clinical Professor of Pharmacy at the University of Washington School of Pharmacy and Director of Anticoagulation Services at the University of Washington Medical Center in Seattle. |
| Steven Meisel is Director of Medication Safety for Fairview Health Services, an integrated health system based in Minneapolis, Minnesota. In this role he is responsible for all aspects of adverse drug event and medication error reduction, as well as related measurement, reporting, educational and cultural initiatives. Dr. Meisel has served as faculty for the Institute for Healthcare Improvement’s Breakthrough Series and related initiatives on adverse drug events, medical errors, and patient safety since 1997.
Dr. Meisel received his Doctor of Pharmacy degree in 1979 and his BS in Pharmacy in 1977 from the Philadelphia College of Pharmacy and Science. Prior to his affiliation with Fairview, he was Clinical Pharmacy Coordinator at St. Joseph's Hospital in St. Paul and Chief of Pharmacy, Keams Canyon Indian Hospital in Arizona.
Dr. Meisel is a member of the American Society of Health-System Pharmacists, the Minnesota Society of Health-System Pharmacists, and the Rho Chi Society. In 2000 he was named one of the state’s top 100 most influential health care leaders by Minnesota Physician. Dr. Meisel was the winner of the 2000 Innovative Solutions Award by the National Patient Safety Foundation, the 2002 Best Practices Award from the American Society of Health-System Pharmacists, and the 2002 Cheers Award from the Institute for Safe Medication Practices. In 2003, the Minnesota Society of Health-System Pharmacists named him the Pharmacist of the Year. He was a finalist for the 2004 Excellence in Medication Use Safety Award from the American Society of Health-System Pharmacists. In 2005 he was the winner of the University Health-System Consortium (UHC) Excellence in Quality and Safety Award. Meisel has authored or co-authored 36 publications.
|
Michael Gulseth, Program Director for Anticoagulation Services, Sanford USD Medical Center
| Michael P. Gulseth is currently an assistant professor at the University of Minnesota College of Pharmacy, Duluth. As part of this role, he also serves as a clinical specialist for anticoagulation services at St. Mary’s Medical Center, also in Duluth, MN. Dr. Gulseth graduated with his Doctor of Pharmacy degree in 1999 from North Dakota State University in Fargo, ND then completed residency training at United Hospital in St. Paul, MN. He currently serves as the Chair of Anticoagulation Services for the Saint Mary’s/Duluth Clinic Health System and is the lead author and editor of the ASHP book, Managing Anticoagulation Patients in the Hospital: the Inpatient Anticoagulation Service. |
Description:
The benefits of anticoagulation therapy continue to be recognized, with their use continually expanding. Anticoagulants, however, have fairly narrow therapeutic windows, and numerous variables exist that can influence responses to therapy and approaches to their use. As such, anticoagulants have been identified as a class of agents frequently associated with adverse medication events. The presence of dedicated individuals familiar with implementation and monitoring anticoagulation therapy, either in the inpatient or outpatient setting, has been shown to improve outcomes related to anticoagulation therapy. To reduce potential mishaps, the Joint Commission has added national patient safety goals for anticoagulation therapy, seeking implementation by institutions by the end of 2008. This program will explore approaches for administrators and clinical staff to recognize and successfully prepare to implement the national patient safety goals.
Learning Objectives:
- Describe key aspects of the new National Patient Safety Goals (NPSG) on anticoagulation.
- Describe examples of ways that have been successfully used to improve the safe use of anticoagulants.
- Explain roles that pharmacists can play in improving the safe use of anticoagulants.
- Identify challenges and strategies for resolving them to fulfill new requirements.
